WO2006038063A1 - Barre nutritive - Google Patents
Barre nutritive Download PDFInfo
- Publication number
- WO2006038063A1 WO2006038063A1 PCT/IB2005/000848 IB2005000848W WO2006038063A1 WO 2006038063 A1 WO2006038063 A1 WO 2006038063A1 IB 2005000848 W IB2005000848 W IB 2005000848W WO 2006038063 A1 WO2006038063 A1 WO 2006038063A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- food bar
- bar according
- food
- acid
- percentage
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 162
- 239000004615 ingredient Substances 0.000 claims abstract description 78
- 239000011230 binding agent Substances 0.000 claims abstract description 22
- 235000016709 nutrition Nutrition 0.000 claims abstract description 19
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 55
- 239000008103 glucose Substances 0.000 claims description 55
- 235000014633 carbohydrates Nutrition 0.000 claims description 42
- 150000001720 carbohydrates Chemical class 0.000 claims description 41
- 239000000843 powder Substances 0.000 claims description 22
- 235000018102 proteins Nutrition 0.000 claims description 22
- 102000004169 proteins and genes Human genes 0.000 claims description 22
- 108090000623 proteins and genes Proteins 0.000 claims description 22
- 235000019197 fats Nutrition 0.000 claims description 21
- 235000013601 eggs Nutrition 0.000 claims description 19
- 235000000346 sugar Nutrition 0.000 claims description 15
- 235000020665 omega-6 fatty acid Nutrition 0.000 claims description 14
- 229940033080 omega-6 fatty acid Drugs 0.000 claims description 14
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 12
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 11
- 239000008101 lactose Substances 0.000 claims description 11
- 241000196324 Embryophyta Species 0.000 claims description 10
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 10
- 229930091371 Fructose Natural products 0.000 claims description 9
- 239000005715 Fructose Substances 0.000 claims description 9
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 9
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 9
- 238000000576 coating method Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 235000013325 dietary fiber Nutrition 0.000 claims description 7
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 7
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 7
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 6
- 241000220317 Rosa Species 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 5
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 108010046377 Whey Proteins Proteins 0.000 claims description 5
- 102000007544 Whey Proteins Human genes 0.000 claims description 5
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 5
- 235000013681 dietary sucrose Nutrition 0.000 claims description 5
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 5
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 5
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 5
- 239000011707 mineral Substances 0.000 claims description 5
- 229960004793 sucrose Drugs 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 241000219730 Lathyrus aphaca Species 0.000 claims description 4
- 208000001145 Metabolic Syndrome Diseases 0.000 claims description 4
- 240000004713 Pisum sativum Species 0.000 claims description 4
- 235000010582 Pisum sativum Nutrition 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 244000299461 Theobroma cacao Species 0.000 claims description 4
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 235000021016 apples Nutrition 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 claims description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 claims description 4
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- 235000010356 sorbitol Nutrition 0.000 claims description 4
- 150000005846 sugar alcohols Chemical class 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 3
- 229920001100 Polydextrose Polymers 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 239000011651 chromium Substances 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 239000001259 polydextrose Substances 0.000 claims description 3
- 235000013856 polydextrose Nutrition 0.000 claims description 3
- 229940035035 polydextrose Drugs 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 235000013406 prebiotics Nutrition 0.000 claims description 3
- 239000011669 selenium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 235000019871 vegetable fat Nutrition 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 235000021119 whey protein Nutrition 0.000 claims description 3
- XSXIVVZCUAHUJO-AVQMFFATSA-N (11e,14e)-icosa-11,14-dienoic acid Chemical compound CCCCC\C=C\C\C=C\CCCCCCCCCC(O)=O XSXIVVZCUAHUJO-AVQMFFATSA-N 0.000 claims description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 235000021357 Behenic acid Nutrition 0.000 claims description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 2
- 241000335053 Beta vulgaris Species 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 235000021297 Eicosadienoic acid Nutrition 0.000 claims description 2
- 241000287828 Gallus gallus Species 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- 239000005642 Oleic acid Substances 0.000 claims description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- 235000021319 Palmitoleic acid Nutrition 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- 241000220324 Pyrus Species 0.000 claims description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- 239000005862 Whey Substances 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 229940116226 behenic acid Drugs 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 235000013330 chicken meat Nutrition 0.000 claims description 2
- 229910052804 chromium Inorganic materials 0.000 claims description 2
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 235000004626 essential fatty acids Nutrition 0.000 claims description 2
- 235000010439 isomalt Nutrition 0.000 claims description 2
- 239000000905 isomalt Substances 0.000 claims description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 2
- 229960004488 linolenic acid Drugs 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 235000021313 oleic acid Nutrition 0.000 claims description 2
- 239000006014 omega-3 oil Substances 0.000 claims description 2
- 235000021017 pears Nutrition 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 229910052711 selenium Inorganic materials 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 235000019155 vitamin A Nutrition 0.000 claims description 2
- 239000011719 vitamin A Substances 0.000 claims description 2
- 235000019156 vitamin B Nutrition 0.000 claims description 2
- 239000011720 vitamin B Substances 0.000 claims description 2
- 235000019166 vitamin D Nutrition 0.000 claims description 2
- 239000011710 vitamin D Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 235000013618 yogurt Nutrition 0.000 claims description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 1
- 244000141359 Malus pumila Species 0.000 claims 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 1
- 229930003270 Vitamin B Natural products 0.000 claims 1
- 229930003268 Vitamin C Natural products 0.000 claims 1
- 229930003316 Vitamin D Natural products 0.000 claims 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims 1
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 1
- 229940046009 vitamin E Drugs 0.000 claims 1
- 229940045997 vitamin a Drugs 0.000 claims 1
- 229940046008 vitamin d Drugs 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 239000008280 blood Substances 0.000 description 35
- 210000004369 blood Anatomy 0.000 description 35
- 238000012360 testing method Methods 0.000 description 17
- 230000002641 glycemic effect Effects 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000004044 response Effects 0.000 description 10
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 235000012054 meals Nutrition 0.000 description 8
- 238000000034 method Methods 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 241000220225 Malus Species 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000036186 satiety Effects 0.000 description 4
- 235000019627 satiety Nutrition 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000003642 hunger Nutrition 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000019788 craving Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000004280 healthy diet Nutrition 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 235000021309 simple sugar Nutrition 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940102884 adrenalin Drugs 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000433 anti-nutritional effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 235000021310 complex sugar Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 235000021149 fatty food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 235000014168 granola/muesli bars Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000001596 intra-abdominal fat Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021084 monounsaturated fats Nutrition 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 235000012794 white bread Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Definitions
- the present invention relates generally to foods and more particularly relates to a food bar.
- a well balanced, healthy diet is well recognized as desirable for physical health. Yet, the maintenance of a healthy diet is not only a persisting but also a growing problem in modern society. Lack of time makes many people choose fast food alternatives, which are often fattening or have an inadequate nutritional value, or even makes people skip entire meals such as breakfast.
- GI glycemic index
- a low GI refers to foods with a GI- value between zero and sixty.
- the GI may be calculated using two different references, that is to say either the reference white bread or the reference glucose.
- Another index has also been devised, in order to estimate the overall glycemic effect of a meal, the concept of glycemic load (“GL”) has been introduced. GL is calculated by dividing GI with one hundred and multiplying it by the dietary carbohydrate content.
- the GL value provides the glycemic effect of realistic portion sizes of different foods.
- the GL value is similar to the GI value, a measure of the rise of the blood glucose and the subsequent secretion of insulin in the blood stream, but including the aspect of the amount of carbohydrates available in a portion of food (see Foster-Powell K., Holt SH., Brand-Miller JC, Am. J. CLIN. NUTR. 76: 5-56,2002, the contents of which are incorporated herein by reference.)
- Carbohydrates are metabolized into glucose by the digestive system of the human body. Until the mid-eighties, it was generally considered that the size of the carbohydrates was of primary importance regarding the blood glucose response. Today, it is known that the same carbohydrate gives rise to different blood glucose responses, due to the form in which it is included in the foods (see e. g. BJORCK L, LILJEBERG H., GRANFELDT Y, Akerberg A. , Scand. J. NUTR./NaRINGSFORSKNING VOL. 40: 38- 42, 1996). Recently, the GI has replaced the terminology of "fast” and "slow” carbohydrates which were related to the size of the sugars included.
- High GI values indicate a rapid increase in blood glucose, and low GI-values indicate a delayed absorption rate for the glucose ; i.e. carbohydrates with low GI- values are more slowly digested and absorbed. As the level of blood glucose is kept at a more even level, feelings of hunger are kept away for a prolonged period also avoiding unnecessary and unhealthy cravings for foods rich in carbohydrates.
- the Gl-value of each of the carbohydrates put together does not determine the GI of the foods.
- the GI is influenced by a number of factors, for example, the biochemical structure of the carbohydrate, a high amylose/amylopectin ratio, a high degree of native starch, presence of anti-nutritional substances with the ability of inhibiting amylose, and the co-ingestion of fat, fibre and protein.
- a problem thus occurs when trying to compose a meal which is to provide the consumer with a low glycemic index for the overall composition. Due to the contribution of a number of factors to the glycemic index, a meal properly balanced so as to avoid fluctuations in the blood glucose level may be difficult to compose.
- Food bars are a known way to provide a convenient, portable, compact and pleasant tasting food that adds energy and nutrients to the body.
- Examples of food bars include candy bars, protein bars, granola bars and the like. While such food bars are often convenient, portable, compact and pleasant tasting, they typically do not provide certain desirable nutritional profiles, in particular addressing the balancing of blood glucose by providing a food product with a suitably low GI/GL value while providing other desired nutritional properties.
- WO2004/011764 teaches a food made of a variety of ingredients which are produced in a powder form, to be mixed with a liquid and consumed by drinking. The ingredients provide a food product having a desired nutrition profile including a low GI- value.
- the food in WO2004/011764 has a desirable nutrition profile that includes a low GI- value
- the resulting food is in powder form, which lacks certain conveniences.
- the powder prior to consumption, the powder is typically mixed with water — adding time to the preparation process, and rendering consumption of the food powder impractical when no water is readily available.
- WO2004/011764 does contemplate the incorporation of the food powder into a food bar, no specific bar formulation is provided therein.
- the inventors of the present invention have determined that when the powder form food ingredients in WO2004/011764 are incorporated into a food bar using traditional binders and carriers, the result is that the binders and carriers themselves result in an undesirable distortion of the nutritional profile of the original powder ingredients, resulting in a food bar having a Gl-value that is higher than desired and also having an otherwise less than desirable nutritional profile.
- a food bar comprised of a set of deliverable ingredients having a nutritional profile that includes a low GI- value.
- the food bar also comprises a binder that is combined with the deliverable ingredients.
- the nutritional profile of the overall bar i.e. the combination of the deliverable ingredients and the binder
- the resulting mixture of the deliverable ingredients and the binder also allows the bar to be shaped as desired.
- the food bar is made from natural or unprocessed ingredients.
- the food bar is used as part of a treatment of metabolic syndrome.
- the ingredients are selected to be in natural, substantially unprocessed form to provide a higher degree of satiety rather that processed and chemically treated substances.
- a food bar including a set of deliverable ingredients and a binder.
- the deliverable ingredients have a nutritional profile that is not substantially altered when combined with the binder.
- the binder allows the deliverable ingredients to be shaped into a bar or other desired configuration.
- the nutritional profile of the deliverable ingredients is typified by a low GI-value.
- the deliverable ingredients include whole egg powder; rose hip powder; yellow peas; whey protein; sugar; and dietary fibres.
- the sugar can be a fruit-based slow carbohydrate, such as fructose.
- sugar ingredients include apples and pears.
- dietary fibres include beet fibre and bran.
- the binder include pre-biotic fibres, such as polydextrose or oligofructose. hi a presently preferred embodiment, the binder is soluble.
- sugar alcohols examples include sorbitol, isomalt and xylitol.
- the food bar can include a coating over the surface of the mass resulting from the combination of the deliverable ingredients and the binder.
- the coating does not substantially alter the nutritional profile of the deliverable ingredients.
- the coating can provide the food bar with a desired flavour, texture and/or color, antioxidants, and also prevent the food bar from drying out and thus increasing the food bar's shelf-life.
- the coating can include vegetable fat, sugar, dark cocoa powder and/or yogurt.
- a single food bar serving is presently preferred to have a mass of from about 30 grams to about 60 grams; more presently preferably from about 35 grams to about 45 grams; and most presently preferably a mass of about 40 grams.
- Deliverable ingredients, binders and coatings, and quantities thereof, suitable for incorporation into a food bar according to the present invention are shown in Tables 1, 2 and 3. Column III of Tables 1, 2 and 3 (labelled as "Presently Preferred") collectively give a specific list of ingredients and quantities thereof suitable for producing a 40 gram food bar in accordance with a specific embodiment of the invention.
- a 40 gram bar made in accordance with Tables 1, 2 and 3 comprises polydextrose, whey protein, fructose, yellow pea powder, whole egg powder, apple, sorbitol, rose hip powder, natural flavours, rape seed oil, sugar beet fibre, ascorbic acid, water, sugar sacarose, vegetable fat, and dark cocoa powder.
- the whole egg powder that is used has a defined content of Omega 3 and Omega 6 fatty acids.
- the ratio of Omega 3 to Omega 6 fatty acids in the whole egg powder can be expressed as X: Y, where X is the proportion of Omega 3 fatty acid; and Y is proportion of the Omega 6 fatty acid.
- X is about 1 ; and Y is between about 0.7 and 1.5.
- X is about 1 ; and Y is about 1.
- the 40 gram food bar (or a variant thereo) dry ingredients including the functional nutrient agents are mixed together in a blender.
- the dry bar mix is furthermore mixed with the binding agents, the rape seed oil, water and preferred liquid flavouring into a baking compound in a modest temperature process (below 50 degrees).
- a modest temperature process below 50 degrees.
- the baking compound is processed and cut into chosen pieces and in the same process covered with a seal of either chocolate or other preferred digestible cover.
- a cooling step is made and finally the ready bar is packed in preferred wrapping material.
- the deliverable ingredients according to the formulation in Column III of Table 1 were balanced with the other ingredients so that one single serving 40 gram food bar contains about 123 kcal.
- the GI of the 40 gram bar of the present invention is presently preferred to be less than about 55, and more presently preferred to be about 35.
- a GI test was devised to determine a food's GI value.
- the GI test involved using measured portions of the food containing about 10 grams to about 50 grams of carbohydrate, fed to at least eight healthy people in the morning after they fasted for about ten to about twelve hours overnight. Finger-prick blood samples were then taken at about 15 to about 30 minute intervals over the next two hours. These blood samples were used to construct a blood sugar response curve for the two hour period.
- the area under the curve (“AUC”) was calculated to reflect the total rise in blood glucose levels after eating the test food.
- the GI value (%) was calculated by dividing the AUC for the test food by the AUC for the reference food (same amount of glucose) and multiplying by one-hundred.
- the use of a standard food was desirable for reducing the confounding influence of differences in the physical characteristics of the subjects. The average of the GI values from all eight subjects is published as the GI of that food.
- the glycemic response is here defined as the AUC for a natural portion of test food (in this case one 40 gram food bar of the present invention) divided by the AUC for 50 grams of glucose, multiplied by one-hundred ⁇ i.e. the GR is given in percent of the response of 50 grams of glucose).
- This GI study is based on a total amount of thirty-two separate test sessions of eight people's blood sugar response on both test food and reference food. Each session was completed on a separate morning with at least one day in between subsequent session.
- portions of foods containing 50 grams of carbohydrate are used in GI studies.
- one 40 gram food bar of the present embodiment contains a very small amount of available digestible carbohydrate, a smaller portion was used when feeding it to the subjects.
- the reference food (glucose) was mixed in 250 ml water and the subjects then were given an extra 250 ml pure water to wash it down with. When eating the bar, the subjects were additionally given 500 ml (250 ml + 250 ml) of pure water to drink. They were told to consume it in a comfortable pace, spreading it out evenly within twelve minutes after the initial fasting blood sample.
- Figures 1A-8A show the response on 10.5 grams of glucose, and 50 grams of glucose
- Figures 1B-8B show the response on one 40 gram bar of the present embodiment, each of which contains 10.5 grams of carbohydrate
- Figure 9 shows the GR results on 50 grams of glucose and on one 40 gram bar of the present embodiment
- Table A shows the response on 10.5 grams of glucose and on one 40 gram bar of the present embodiment
- Table B shows the results on 10.5 grams of glucose, 50 grams of glucose, and on one 40 gram bar of the present embodiment.
- the GI value of the 40 gram bar of the present embodiment was calculated to be about 35%, when 100% is defined as the area under curve for 10.5 grams of glucose, (i.e. the same amount of carbohydrate as in one bar).
- the GR of 50 grams of glucose is defined as 100%, the GR of 10.5 grams of glucose was found to be about 28%, and for one 40 gram food bar of the present invention, the GR was found to be about 10% (i.e. the AUC for one food bar of the present invention was only 10% of the AUC for 50 grams of glucose).
- the deliverable ingredients can be selected such that the relative amounts of the components, carbohydrates, proteins and fat of the deliverable ingredients are chosen such that an intake of the deliverable ingredients provides the consumer with a substantially stable blood glucose level.
- a substantially stable blood glucose level can be achieved by providing deliverable ingredients so that the overall bar has a GL- value below about 10, preferably below about 5, more preferably about 2.7, and still more preferably about 1.
- the deliverable ingredients preferably have a mass ratio between carbohydrates, proteins and fat of about 0.8-2.0:1.0:0.1-1.2, more preferably about 1.0- 1.8:1.0:0.2-1.0, still more preferably about 1.2-1.6:1.0:0.4-0.8, and even more preferably about 1.4:1.0:0.6 respectively, wherein the carbohydrates are chosen from the group of foods having a low glycemic index.
- the carbohydrates, proteins and fat i.e. the deliverable ingredients
- the carbohydrates of the deliverable ingredients can be derived from leguminous plants such as yellow peas, and rosaceous plants such as rose hips, wherein the leguminous plants provide a high amount of simple sugars such as fructose, and the leguminous plants and rosaceous plants contribute in giving the deliverable ingredients its advantageously low GL- value.
- carbohydrate source is, as also mentioned, another factor in obtaining a low GL for the deliverable ingredients. Accordingly, carbohydrates having low GI- values are chosen. According to one embodiment of the invention the deliverable ingredients has a content comprising yellow peas, apples, and rose hips as described above, all of which comprise carbohydrates with low GI- values.
- the carbohydrates when decomposed can provide the human body system with simple sugars from the group comprising glucose, saccharose, fructose, maltose and lactose.
- Glucose is can be present in a percentage of from about 0.5% to about 2.0%, and more preferably about 1.0%.
- Saccharose is can be present in a percentage of from about 3.0% to about 6.0%, and more preferably about 4.4%.
- Fructose can be present in a percentage of from about 7.0% to about 15.0%, and more preferably about 11.0%.
- Maltose can be present in a percentage of from less than about 0.03% to about 0.05%, and more preferably less than about 0.04 %.
- Lactose can be preferably present in a percentage of from about 0.30% to about 0.80%, and more preferably about 0.56%. Percentages are based on the overall content of deliverable ingredients.
- the carbohydrates when decomposed provide the human body system with low amounts of lactose.
- the carbohydrates do not provide any lactose at all.
- a low lactose product is directed to people who cannot tolerate lactose. It will be understood by those of skill in the art that less than about 1% lactose content per serving is recognized as low lactose content.
- Physiological doses of dietary fibres are present in the deliverable ingredients in a percentage of from about 7% to about 12%, and more preferably about 8.4%.
- the GL of a meal is affected by the content of fibres, as a high degree of fibres helps to lower the glycemic index. Fibres are not digested, but are however necessary in order for the bowels to function correctly.
- the high content of fibres in the deliverable ingredients according to the invention is advantageous in improving motility (bowel movements) and thus enhancing the consumer's ability to process food efficiently.
- the fibres help the elimination of toxins in the cells and furthermore is recognized to reduce the cholesterol content in the blood system.
- the fat of the deliverable ingredients comprises the essential fatty acids with an omega-3 to omega-6 fatty acid ratio preferably of from about 1.0:0.5 to about 1.0:6.0, more preferably from about 1.0:1.0 to about 1.0:4.0, still more preferably from about 1.0: 1.5 to about 1.0:2.5, and even more preferably about 1.0:2.0.
- the fatty acids are preferably chosen from the group consisting of myristic acid, palmitic acid, palmitoleic acid, heptadecanoic acid, stearic acid, oleic acid, linoleic acid, alfa-linolenic acid, arachidic acid, eicosadienoic acid, behenic acid, docosahexaenoic acid (“DHA”) and eicosapentaenoic acid (“EPA”).
- DHA docosahexaenoic acid
- EPA eicosapentaenoic acid
- the invention is not restricted to the fatty acids mentioned herein. Other fatty acids which are within the scope of the invention may also be chosen.
- the levels of DHA and EPA are optimized and preferably constitute from about 1.0% to about 3.0%, more preferably from about 1.9% to about 2.3%, and even more preferably about 2.1% of the total fat.
- Cholesterol is also present in amounts which meet the body's needs.
- the fat of the deliverable ingredients is substantially derived from whole eggs. It is presently preferred that the whole eggs have a desirable balance between omega 3 and omega 6 fatty acids, hi order to achieve a desirable balance between saturated, monounsaturated and polyunsaturated fat, the whole egg content in the deliverable ingredients is supplied from chickens that are fed with a desired feed. A desired feed is rich in omega 3 and omega 6 fatty acids.
- the fat of the deliverable ingredients can also be derived from sources other than whole eggs. For example, omega 6 fatty acids can also be derived from rape seed oil.
- Protein is present in the deliverable ingredients in an amount of about 30 grams to about 45 grams, more preferably about 35 grams to about 40 grams, and more preferably about 37 grams to about 39 grams per 100 grams of deliverable ingredients.
- the protein present in the deliverable ingredients preferably contains all twenty amino acids, including the eight recognized essential amino acids in physiological doses.
- the amino acids are suitably derived from sources such as whey, yellow pea, egg albumen, and whole eggs.
- the deliverable ingredients according to the invention provide a daily allowance of protein and essential amino acids.
- the content of protein further provides a positive nitrogen balance to promote water excretion, visceral fat utilization and lean body mass preservation.
- a balance of vitamins can be desirable for assisting in the conversion of food into energy, and the maintenance of the body.
- vitamins C and E can be added as desirable antioxidants.
- Vitamins A, B, C, D, and E can be added to the deliverable ingredients in physiological doses.
- minerals can be added to the deliverable ingredients in physiological doses.
- desirable minerals can include iron (Fe), zinc (Zn), calcium (Ca), phosphorus (P), magnesium (Mg), copper (Cu), manganese (Mn), chromium (Cr), selenium (Se), silica (Si), potassium (K), and sodium (Na). It is presently preferred that potassium be added in high amounts, and sodium in small amounts.
- Minerals are presently desirable for the metabolic processes in the body. They act as catalysts for the major body processes, wherein they act in an interrelated manner. A lack of minerals in the body can create a deficiency, and an excess can create disturbances in the body process.
- the 40 gram food bar has a pH of about 5.8 to about 6.2 and acts like a buffer, thus having a positive effect on people suffering from G.E.R.D. (gastroesophageal reflux disease) and Non Ulcer Dyspepsia.
- G.E.R.D. gastroesophageal reflux disease
- Non Ulcer Dyspepsia G.E.R.D.
- the present invention provides a novel food bar.
- the food bar can have a satiating effect for a longer period of time after a consumed meal, which keeps feelings of hunger away.
- different foods differ greatly in their satiating capacities.
- the deliverable ingredients can provide the satiating effect due to a number of reasons mentioned in the study above.
- the low degree of fat in the deliverable ingredients is desirable because fatty foods are shown not to be satisfying. Further, the inclusion of foods such as eggs and apples are desirable, because both have a high satiety index, as defined in the above-noted article. Furthermore, the deliverable ingredients according to the invention have a balanced ratio between certain desirable components such as the contents of protein, fibre, and water. The components are shown in the above mentioned study to have a positive effect on satiety.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Pediatric Medicine (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002483675A CA2483675A1 (fr) | 2004-10-01 | 2004-10-01 | Barre alimentaire |
CA2,483,675 | 2004-10-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006038063A1 true WO2006038063A1 (fr) | 2006-04-13 |
Family
ID=34963721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/000848 WO2006038063A1 (fr) | 2004-10-01 | 2005-03-31 | Barre nutritive |
Country Status (2)
Country | Link |
---|---|
CA (1) | CA2483675A1 (fr) |
WO (1) | WO2006038063A1 (fr) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008017661A1 (fr) | 2006-08-07 | 2008-02-14 | Novozymes A/S | Granules d'enzyme pour alimentation animale |
WO2016111843A1 (fr) * | 2015-01-07 | 2016-07-14 | Government Of The United States Of America, As Represented By The Secretary Of The Navy | Compositions et méthodes pour le diagnostic et le traitement du syndrome métabolique |
EP3072399A1 (fr) | 2006-08-07 | 2016-09-28 | Novozymes A/S | Granules d'enzyme pour alimentation animale |
US9662306B2 (en) | 2015-01-07 | 2017-05-30 | The United States Of America, As Represented By The Secretary Of The Navy | Compositions and methods for diagnosis and treatment of metabolic syndrome |
US10449170B2 (en) * | 2015-01-07 | 2019-10-22 | United States Of America As Represented By Secretary Of The Navy | Compositions for diagnosis and treatment of type 2 diabetes |
US10792266B2 (en) | 2017-10-23 | 2020-10-06 | Epitracker, Inc. | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome |
US10874131B2 (en) | 2017-12-22 | 2020-12-29 | Heliae Development Llc | Human and non-human animal use of microbial anaplerotic oil |
US11992473B2 (en) | 2018-05-23 | 2024-05-28 | Epitracker, Inc. | Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0306773A2 (fr) * | 1987-09-05 | 1989-03-15 | MERCK PATENT GmbH | Liant sans sucre |
US6140304A (en) * | 1988-09-28 | 2000-10-31 | Eicotech Corporation | Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia |
WO2002064090A2 (fr) * | 2001-02-14 | 2002-08-22 | Advanced Functional Foods International, Inc. | Complement alimentaire permettant d'attenuer les symptomes lies au stress et taux reduits de serotonine |
US20020122815A1 (en) * | 2001-01-04 | 2002-09-05 | Peroutka Stephen J. | Compositions and methods of carbohydrate dosing |
WO2004017764A1 (fr) * | 2002-08-26 | 2004-03-04 | Ebn International Kft | Substitut de repas complet |
US20040137112A1 (en) * | 2002-11-28 | 2004-07-15 | Saul Katz | Low glycemic index food |
EP1447014A1 (fr) * | 2003-02-14 | 2004-08-18 | Wacker-Chemie GmbH | Procédé pour réduire l'index glycémique des aliments |
-
2004
- 2004-10-01 CA CA002483675A patent/CA2483675A1/fr not_active Abandoned
-
2005
- 2005-03-31 WO PCT/IB2005/000848 patent/WO2006038063A1/fr active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0306773A2 (fr) * | 1987-09-05 | 1989-03-15 | MERCK PATENT GmbH | Liant sans sucre |
US6140304A (en) * | 1988-09-28 | 2000-10-31 | Eicotech Corporation | Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia |
US20020122815A1 (en) * | 2001-01-04 | 2002-09-05 | Peroutka Stephen J. | Compositions and methods of carbohydrate dosing |
WO2002064090A2 (fr) * | 2001-02-14 | 2002-08-22 | Advanced Functional Foods International, Inc. | Complement alimentaire permettant d'attenuer les symptomes lies au stress et taux reduits de serotonine |
WO2004017764A1 (fr) * | 2002-08-26 | 2004-03-04 | Ebn International Kft | Substitut de repas complet |
US20040137112A1 (en) * | 2002-11-28 | 2004-07-15 | Saul Katz | Low glycemic index food |
EP1447014A1 (fr) * | 2003-02-14 | 2004-08-18 | Wacker-Chemie GmbH | Procédé pour réduire l'index glycémique des aliments |
Non-Patent Citations (1)
Title |
---|
PAINTER J E ET AL: "THE EFFECTS OF VARIOUS PROTEIN AND CARBOHYDRATE IN ENERGY BARS ON BLOOD GLUCOSE LEVELS IN HUMANS", CEREAL FOODS WORLD, AMERICAN ASSOCIATION OF CEREAL CHEMISTS, ST. PAUL, MN, US, vol. 47, no. 6, June 2002 (2002-06-01), pages 236 - 241, XP009048636, ISSN: 0146-6283 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008017661A1 (fr) | 2006-08-07 | 2008-02-14 | Novozymes A/S | Granules d'enzyme pour alimentation animale |
EP3072399A1 (fr) | 2006-08-07 | 2016-09-28 | Novozymes A/S | Granules d'enzyme pour alimentation animale |
WO2016111843A1 (fr) * | 2015-01-07 | 2016-07-14 | Government Of The United States Of America, As Represented By The Secretary Of The Navy | Compositions et méthodes pour le diagnostic et le traitement du syndrome métabolique |
US9561206B2 (en) | 2015-01-07 | 2017-02-07 | The United States Of America, As Represented By The Secretary Of The Navy | Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome |
US9662306B2 (en) | 2015-01-07 | 2017-05-30 | The United States Of America, As Represented By The Secretary Of The Navy | Compositions and methods for diagnosis and treatment of metabolic syndrome |
US10449170B2 (en) * | 2015-01-07 | 2019-10-22 | United States Of America As Represented By Secretary Of The Navy | Compositions for diagnosis and treatment of type 2 diabetes |
US10449171B2 (en) * | 2015-01-07 | 2019-10-22 | United States Of America As Represented By Secretary Of The Navy | Compositions and methods for diagnosis and treatment of metabolic syndrome |
US10792266B2 (en) | 2017-10-23 | 2020-10-06 | Epitracker, Inc. | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome |
US11951088B2 (en) | 2017-10-23 | 2024-04-09 | Epitracker, Inc. | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome |
US10874131B2 (en) | 2017-12-22 | 2020-12-29 | Heliae Development Llc | Human and non-human animal use of microbial anaplerotic oil |
US11992473B2 (en) | 2018-05-23 | 2024-05-28 | Epitracker, Inc. | Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity |
Also Published As
Publication number | Publication date |
---|---|
CA2483675A1 (fr) | 2006-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006038063A1 (fr) | Barre nutritive | |
EP1531689B1 (fr) | Substitut de repas complet | |
Oyarekua | Evaluation of the nutritional and microbiological status of co-fermented cereals/cowpea ‘OGI’ | |
CN109645079A (zh) | 一种具有减肥作用的代餐压缩饼干及其制备和应用 | |
CA2405012A1 (fr) | Metabolisme de sous-types d'amidons et de lipides | |
GB2412834A (en) | A ready-to-use nutritional supplement | |
Gambuś et al. | Perspectives of linseed utilisation in baking. | |
WO2005099483A1 (fr) | Composition pouvant etre ingeree | |
CN109845894A (zh) | 一种猫用宠物饼干及加工方法 | |
US20050202063A1 (en) | Food product | |
CN110810468B (zh) | 一种生酮曲奇及其制备方法 | |
CN108308621A (zh) | 一种富含大米低聚肽的减肥代餐粉 | |
Oyet et al. | Amino acid profile, mineral bioavailability, and sensory properties of biscuits produced from composite blends of wheat, coconut and defatted fluted pumpkin seed flour | |
US20030161861A1 (en) | Use of a cereal product for improving cognitive performance and mental well-being in a person, particularly in a child and an adolescent | |
Bengoa et al. | Nutritional goals for health in Latin America | |
Eaton | Preagriculturals diets and evolutionary health promotion | |
NL7903304A (nl) | Voedingsmiddelsamenstelling. | |
CN1314353C (zh) | 蛋白互补粉 | |
CN109007855A (zh) | 一种降低体脂百分比的营养代餐组合物 | |
DE69937396T2 (de) | Eiweisskomplement, dieselben enthaltende lebensmittelzubereitung, verfahren zu ihrer herstellung und anwendung derselben | |
Emelike et al. | Nutrient composition and sensory properties of wheat bread substituted with defatted and undefatted cashew kernel (Anacardium occidentale Linn.) flours | |
Kabylda et al. | STUDY OF THE INFLUENCE OF STARCH ON THE QUALITY INDICATORS OF GLUTEN-FREE PASTA | |
KUDVA | “FORMULATION AND QUALITY EVALUATION OF SESAME-PUMPKIN BURFI” Project work submitted to DEPARTMENT OF PG STUDIES IN FOOD SCIENCE AND NUTRITION | |
Rajaram et al. | Nutrition and vegetarianism | |
Register et al. | Nutritionally adequate vegetarian diets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05718326 Country of ref document: EP Kind code of ref document: A1 |